[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370114-105":59,"doc-detail-370114-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","cancer-prevalence-and-prognosis-among-individuals-living-with-hiv-and-aids-in-turkey-multicenter-buhasder-study","Cancer prevalence and prognosis among individuals living with HIV and AIDS in Turkey - Multicenter BUHASDER study","","This multicentre retrospective cohort study assessed cancer prevalence, distribution, and risk factors among people living with HIV (PLWH) in Turkey across two decades, and examined related mortality outcomes. Data from medical records included 154 adults diagnosed with both cancer and HIV between 2008 and 2024. Analyses included multivariate logistic regression and Cox regression for risk factors, and Kaplan-Meier estimates for survival. Results reported cancer prevalence of 1.8% and quantified ADC versus NADC patterns and survival.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cancer-prevalence-and-prognosis-among-individuals-living-with-hiv-and-aids-in-turkey-multicenter-buhasder-study/370114/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cancer-prevalence-and-prognosis-among-individuals-living-with-hiv-and-aids-in-turkey-multicenter-buhasder-study/370114.png","ImageObject",300,407,{"name":92,"@type":93},"pixelkiddo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What question did the multicentre BUHASDER study address?","Question",{"text":112,"@type":113},"It evaluated cancer prevalence, distribution, and risk factors among people living with HIV in Turkey over two decades, and also investigated mortality rates and related factors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were outcomes and risk factors analyzed?",{"text":117,"@type":113},"Risk factors for ADCs and mortality were assessed using multivariate logistic regression and Cox regression, while estimated survival time used Kaplan-Meier analysis.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main findings on cancer prevalence and common cancer types?",{"text":121,"@type":113},"Among 8708 PLWH, cancer prevalence was 1.8%. The most prevalent cancers were non-Hodgkin lymphoma (35.1%), Kaposi sarcoma (29.9%), and lung cancer (7.8%).",{"name":123,"@type":110,"acceptedAnswer":124},"Which factors were associated with ADCs and mortality?",{"text":125,"@type":113},"Age ≤54 years, CD4+ T lymphocyte count ≤94/mm3, and HHV-8 co-infection were risk factors for ADCs. Non-Hodgkin lymphoma and CD4+ T lymphocyte count ≤232/mm3 at treatment completion predicted mortality.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},370114,1790298601,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},962090883892,"https://ap-avatar.wpscdn.com/avatar/e00115db34f3e0f11b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1790152879550218658","Original research article  \nCancer prevalence and prognosis among individuals living with HIV and AIDS in Turkey: Multicenter BUHASDER study  \nInternational Journal of STD & AIDS 2026, Vol. 37(5) 500–510 © The Author(s) 2025  \nArticle reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/09564624251405965](DOI: 10.1177/09564624251405965)  \n[journals.sagepub.com/home/std](journals.sagepub.com/home/std)  \n¨Ozlem Güler 1 􀀁, Sıla Akhan1, Atahan Ça˘gatay2, Aye Batırel3, Elif Sargın Altunok3, Sibel Bolukçu3 􀀁, Hülya ¨Ozkan ¨Ozdemir4, Emine ˙Ilay Duman4, Müge Toygar Deniz 1 􀀁 , Derya ¨Ozyi˘gito˘glu5, Kemalettin ¨Ozden6, Handan Alay6, Derya Seyman7, Melda Türken8, S¸ebnem Çalık8, ¨Ozge Çaydaı9, Derya ¨Oztürk Engin9, ¨Ozgür Günal 10, S¸eyma Topal10, O˘guz Karabay 11, Figen Sarıgül12, Hanife Nur Karakoç Parlayan 13 􀀁, Ayin Kılınç Toker14,¨Ozlem Aydın15, Emre Bayhan 16, Pınar Ergen15, Nevin ˙Ince 17, S¸afak Kaya18,  \nSelcan Arslan ¨Ozel 19, Aybegüm ¨Ozahin20, Esra Gürbüz21, Ahmet S¸ ahin22, Sibel Balcı23 and S¸ ükran Kse24  \nAbstract  \nBackground: This multicentre study evaluated the prevalence, distribution, and risk factors of cancer among people living with HIV (PLWH) in Turkey over two decades. Mortality rates and factors were also investigated.  \nMethods: This retrospective cohort study included 154 adults diagnosed with cancer and HIV between 2008 and 2024. Data were collected from the medical records. The demographics, clinical characteristics, cancer types, treatments, and  \n1 Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Kocaeli University, Kocaeli, Turkey  \n2Istanbul Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Istanbul University, Istanbul, Turkey  \n3Department of Infectious Diseases and Clinical Microbiology, Kartal Dr Lütﬁ Kırdar City Hospital, Health Sciences University, Istanbul, Turkey 4Department of Infectious Diseases and Clinical Microbiology, Izmir Education and Research Hospital, Health Sciences University, Izmir, Turkey 5Department of Infectious Diseases and Clinical Microbiology, Abdulhamid Han Education and Research Hospital, Istanbul, Turkey  \n6Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Atatürk University, Erzurum, Turkey  \n7Department of Infectious Diseases and Clinical Microbiology, Antalya Education and Research Hospital, Health Sciences University, Antalya, Turkey 8Izmir Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Izmir City Hospital, Health Sciences University, Izmir, Turkey 9Department of Infectious Diseases and Clinical Microbiology, Health Sciences University Sancaktepe ehit Prof. Dr ˙Ilhan Varank Education And Research Hospital, Istanbul, Turkey  \n10Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Samsun University, Samsun, Turkey  \n11 Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Sakarya University, Sakarya, Turkey  \n12Department of Infectious Diseases and Clinical Microbiology, Antalya Life Hospital, Antalya, Turkey  \n13Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Karadeniz Technical University, Trabzon, Turkey 14Department of Infectious Diseases and Clinical Microbiology, Kayseri City Hospital, Kayseri, Turkey  \n15Department of Infectious Diseases and Clinical Microbiology, Gztepe Education and Research Hospital, Istanbul Medeniyet University, Istanbul, Turkey 16Department of Infectious Diseases and Clinical Microbiology, Adıyaman Education and Research Hospital, Adıyaman, Turkey  \n17Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Düzce University, Düzce, Turkey  \n18Department of Infectious Diseases and Clinical Microbiology, Gazi Yasargil Education and Research Hospital, Health Sciences University, Diyarbakır, Turkey  \n19Department ","cbCaitsVtKejc7iw","https://ap.wps.com/l/cbCaitsVtKejc7iw","pdf",712081,11,"English","## Background\n## Methods\n## Results\n## Conclusions","[{\"question\":\"What question did the multicentre BUHASDER study address?\",\"answer\":\"It evaluated cancer prevalence, distribution, and risk factors among people living with HIV in Turkey over two decades, and also investigated mortality rates and related factors.\"},{\"question\":\"How were outcomes and risk factors analyzed?\",\"answer\":\"Risk factors for ADCs and mortality were assessed using multivariate logistic regression and Cox regression, while estimated survival time used Kaplan-Meier analysis.\"},{\"question\":\"What were the main findings on cancer prevalence and common cancer types?\",\"answer\":\"Among 8708 PLWH, cancer prevalence was 1.8%. The most prevalent cancers were non-Hodgkin lymphoma (35.1%), Kaposi sarcoma (29.9%), and lung cancer (7.8%).\"},{\"question\":\"Which factors were associated with ADCs and mortality?\",\"answer\":\"Age ≤54 years, CD4+ T lymphocyte count ≤94/mm3, and HHV-8 co-infection were risk factors for ADCs. Non-Hodgkin lymphoma and CD4+ T lymphocyte count ≤232/mm3 at treatment completion predicted mortality.\"}]","Cancer prevalence and prognosis among individuals living with HIV and AIDS in Turkey - Multicenter BUHASDER study | PDF",1790186804,28,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a67cc5743a8a459c32ef08a3663453e1.webp",983,1310,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50627edc417b73b64970f3425923f9f9.webp",982,1309,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f72a319c160aa8eb558ade61ab6c9606.webp",981,1308,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/37c84732d5893deafeb145a4bab25fed.webp",980,1306]